CRH - CRH plc
NYSE
->
Basic Materials
->
Building Materials
Dublin,
Ireland
Type: Equity
CRH price evolution
CRH
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $6422 | $5893 | $4798 | $4507 |
| Inventory | $4644 | $4514 | $4619 | $4291 |
| Total current assets | $14840 | $15113 | $13709 | $16885 |
| Long term investments | ||||
| Property, plant & equipment | $22611 | $20514 | $20163 | $19133 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $51221 | $48105 | $46333 | $47469 |
| Current liabilities | ||||
| Accounts payable | $2963 | $3363 | $2730 | $3149 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $10668 | $10548 | $9997 | $10013 |
| Long term debt | $10840 | $9900 | $9680 | $10901 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $29346 | $27379 | $26318 | $26615 |
| Shareholders' equity | ||||
| Retained earnings | $23831 | $23030 | $22346 | $22918 |
| Other shareholder equity | -$499 | -$813 | -$797 | -$616 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2025 | 31 Jan 2024 | 31 Jan 2023 | 11 Mar 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6341 | $873 | $5783 | |
| Short term investments | $478 | $102 | $81 | |
| Net receivables | $4507 | $4632 | $4569 | |
| Inventory | $4291 | $4194 | $3611 | |
| Total current assets | $16885 | $14801 | $14044 | |
| Long term investments | $30584 | $30387 | $30626 | |
| Property, plant & equipment | $19133 | $18921 | $19502 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $47469 | $45188 | $44670 | |
| Current liabilities | ||||
| Accounts payable | $3149 | $5872 | $5692 | |
| Deferred revenue | ||||
| Short long term debt | $1866 | $1751 | $846 | |
| Total current liabilities | $10013 | $8889 | $7581 | |
| Long term debt | $10901 | $9204 | $11312 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $26615 | $23497 | $24437 | |
| Shareholders' equity | ||||
| Retained earnings | $22918 | $22372 | $19770 | |
| Other shareholder equity | -$616 | -$687 | $348 | |
| Total shareholder equity | $20854 | $21691 | $20233 | |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $6533 | $34949 | ||
| Cost of revenue | ||||
| Gross Profit | $1807 | $11963 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1787 | $7777 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$19 | $925 | ||
| Interest expense | -$90 | -$170 | ||
| Net income | ||||
| Net income | $116 | $3178 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 10 Mar 2023 | 11 Mar 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $34949 | $32723 | $30981 | $27587 |
| Cost of revenue | $21844 | $20493 | $18171 | |
| Gross Profit | $11963 | $10879 | $10488 | $9416 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $6985 | $6903 | $6910 | |
| Total operating expenses | $7486 | $28829 | $27341 | $25081 |
| Operating income | $3894 | $3640 | $2506 | |
| Income from continuing operations | ||||
| EBIT | $3894 | $3640 | $2506 | |
| Income tax expense | $925 | $785 | $721 | $499 |
| Interest expense | -$170 | -$354 | ||
| Net income | ||||
| Net income | $3178 | $3847 | $2565 | $1122 |
| Income (for common shares) | $3847 | $2565 | $1122 | |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$4405 | -$2617 | -$2096 | -$2391 |
| Financing activities | ||||
| Dividends paid | -$1469 | -$1231 | -$750 | -$940 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$1144 | -$515 | -$176 | -$2380 |
| Effect of exchange rate | -$20 | -$85 | -$97 | $208 |
| Change in cash and equivalents | -$3310 | -$2444 | -$3081 | $454 |
| (in millions $) | 31 Jan 2024 | 10 Mar 2023 | 11 Mar 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $3847 | $2565 | $1122 | |
| Operating activities | ||||
| Depreciation | $1757 | $1765 | $1694 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $5371 | $5253 | $3938 | |
| Investing activities | ||||
| Capital expenditures | -$1523 | -$1554 | -$996 | |
| Investments | ||||
| Total cash flows from investing | -$2391 | -$884 | -$2546 | -$1060 |
| Financing activities | ||||
| Dividends paid | -$940 | -$707 | ||
| Sale and purchase of stock | ||||
| Net borrowings | $4917 | $6294 | $1226 | |
| Total cash flows from financing | -$2380 | -$2686 | -$3305 | $287 |
| Effect of exchange rate | $208 | $338 | ||
| Change in cash and equivalents | $454 | $153 | -$3705.95 | $3503 |
News
Fundamentals
| Market cap | $89.08B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 705.79M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.39 |
| Quick ratio | 0.96 |